TY - JOUR
T1 - Combination of light-emitting diode with minoxidil 2%, topical corticosteroid and oral immunomodulator induced hair regrowth in a pediatric alopecia areata
AU - Evyana, Dina
AU - Legiawati, Lili
AU - Rahmayunita, Githa
AU - Sitohang, Irma Bernadette S.
AU - Surachmiati, Lis
AU - Kusumawardhani, Dina
N1 - Publisher Copyright:
© 2023 Pakistan Association of Dermatologists. All rights reserved.
PY - 2023/1
Y1 - 2023/1
N2 - Alopecia areata (AA) is a form of non-scarring hair loss caused by an autoimmune disease. Symptoms range from a total or severe to an only mild patchy loss of hair. Spontaneous remission may occur. Even though AA is the third most frequent reason for pediatric dermatology consultations, treating alopecia areata in children is still difficult. A 4-year-old, healthy girl, presented with non-scarring multiple patchy alopecias on the scalp, and the hair pull test was positive. Trichoscopy demonstrated exclamation marks, black dots, short vellus hairs, and telangiectasia. Routine laboratory tests were unremarkable. The patient was clinically diagnosed with alopecia areata. Dermoscopy may confirm the diagnosis. Therapies are designed to alleviate symptoms and signs. More pediatric data are needed to evaluate therapies' safeness and recurrence rates in such treatment approaches. Topical treatment using high potency topical corticosteroid and minoxidil 2% combined with light-emitting-diode (LED) and oral immunomodulator (inosine pranobex) showed good response and well tolerated in pediatric alopecia areata.
AB - Alopecia areata (AA) is a form of non-scarring hair loss caused by an autoimmune disease. Symptoms range from a total or severe to an only mild patchy loss of hair. Spontaneous remission may occur. Even though AA is the third most frequent reason for pediatric dermatology consultations, treating alopecia areata in children is still difficult. A 4-year-old, healthy girl, presented with non-scarring multiple patchy alopecias on the scalp, and the hair pull test was positive. Trichoscopy demonstrated exclamation marks, black dots, short vellus hairs, and telangiectasia. Routine laboratory tests were unremarkable. The patient was clinically diagnosed with alopecia areata. Dermoscopy may confirm the diagnosis. Therapies are designed to alleviate symptoms and signs. More pediatric data are needed to evaluate therapies' safeness and recurrence rates in such treatment approaches. Topical treatment using high potency topical corticosteroid and minoxidil 2% combined with light-emitting-diode (LED) and oral immunomodulator (inosine pranobex) showed good response and well tolerated in pediatric alopecia areata.
KW - Alopecia areata
KW - diode
KW - immunomodulator
KW - pediatric
UR - http://www.scopus.com/inward/record.url?scp=85147448064&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85147448064
SN - 1560-9014
VL - 33
SP - 339
EP - 341
JO - Journal of Pakistan Association of Dermatologists
JF - Journal of Pakistan Association of Dermatologists
IS - 1
ER -